Literature DB >> 10899648

Prevalence of complementary therapy use by women with breast cancer. A population-based survey.

R W Rees1, I Feigel, A Vickers, C Zollman, R McGurk, C Smith.   

Abstract

The study measured the prevalence and costs of complementary therapy use by women diagnosed with breast cancer in the South Thames NHS region. A postal questionnaire was sent to a sample of 1023 women from the Thames Cancer Registry who had been diagnosed with breast cancer in the previous 7 years. Just over a fifth (22.4%) had consulted a complementary practitioner in the previous 12 months. Almost one third (31.5%) had done so since diagnosis. Almost pound17000 had been spent on visits in the previous year. The women using complementary medicine after diagnosis were slightly younger, more educated and more likely to have used complementary medicine before their diagnosis than non-complementary medicine users. In conclusion, significant numbers of women are visiting complementary therapists for health reasons following a breast cancer diagnosis. The out of pocket costs per user, with notable exceptions, are modest. Use of practitioners of complementary therapies following diagnosis is a significant and possibly growing phenomenon.

Entities:  

Mesh:

Year:  2000        PMID: 10899648     DOI: 10.1016/s0959-8049(00)00099-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  30 in total

1.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  BMC Complement Altern Med       Date:  2012-01-12       Impact factor: 3.659

3.  Complementary and alternative medicine use in breast cancer patients in Europe.

Authors:  Alexander Molassiotis; Julia A Scott; Nora Kearney; Dorit Pud; Miriam Magri; Sarka Selvekerova; Ingrid Bruyns; Paz Fernadez-Ortega; Vassiliki Panteli; Anita Margulies; Gudbjorg Gudmundsdottir; Ljiljana Milovics; Gulten Ozden; Nurgun Platin; Elisabeth Patiraki
Journal:  Support Care Cancer       Date:  2005-09-06       Impact factor: 3.603

4.  Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality.

Authors:  Eran Ben-Arye; Gil Bar-Sela; Moshe Frenkel; Abraham Kuten; Doron Hermoni
Journal:  Support Care Cancer       Date:  2005-08-16       Impact factor: 3.603

5.  Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.

Authors:  Bahadir M Gulluoglu; Asim Cingi; Tebessum Cakir; Afsar Barlas
Journal:  Breast Care (Basel)       Date:  2008-08-11       Impact factor: 2.860

6.  Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey.

Authors:  G Nagel; H Hoyer; D Katenkamp
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

Review 7.  Massage therapy for essential hypertension: a systematic review.

Authors:  X J Xiong; S J Li; Y Q Zhang
Journal:  J Hum Hypertens       Date:  2014-07-03       Impact factor: 3.012

Review 8.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

Review 9.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

10.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.